Metrics to compare | 223250 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship223250PeersSector | |
|---|---|---|---|---|
P/E Ratio | 303.0x | 8.1x | −0.2x | |
PEG Ratio | −3.17 | 0.02 | 0.00 | |
Price/Book | 1.3x | 1.1x | 2.6x | |
Price / LTM Sales | 1.4x | 2.2x | 2.8x | |
Upside (Analyst Target) | - | 72.9% | 64.8% | |
Fair Value Upside | Unlock | 24.4% | 9.7% | Unlock |
DreamCIS, Inc. operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada. It offers clinical development services; standalone services, including biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea. DreamCIS, Inc. operates as a subsidiary of Hangzhou Tigermed Consulting Co., Ltd.